Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9).
about
Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease.What is the impact of PCSK9 rs505151 and rs11591147 polymorphisms on serum lipids level and cardiovascular risk: a meta-analysisPCSK9 inhibitors - from discovery of a single mutation to a groundbreaking therapy of lipid disorders in one decade.The Relationship of Novel Plasma Proteins in the Early Neonatal Period With Retinopathy of Prematurity.Enhanced pro-protein convertase subtilisin/kexin type 9 expression by C-reactive protein through p38MAPK-HNF1α pathway in HepG2 cells.PCSK9 targets important for lipid metabolismAlirocumab for the treatment of hypercholesterolaemia.The role of insufficient copper in lipid synthesis and fatty-liver disease.Clinical utility of evolocumab in the management of hyperlipidemia: patient selection and follow-up.Oxidized low-density lipoprotein (oxLDL) affects load-free cell shortening of cardiomyocytes in a proprotein convertase subtilisin/kexin 9 (PCSK9)-dependent way.Using Human 'Experiments of Nature' to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors.Sirolimus Therapy Is Associated with Elevation in Circulating PCSK9 Levels in Cardiac Transplant Patients.Simplified algorithm to facilitate communication of familial hypercholesterolaemia.6-Gingerol Regulates Hepatic Cholesterol Metabolism by Up-regulation of LDLR and Cholesterol Efflux-Related Genes in HepG2 Cells.Novel insights on the treatment of hypercholesterolemia
P2860
Q33599961-76367676-7A9C-4C93-9181-41CF51149292Q33792275-341E54C7-3A45-4700-AFB6-3E9A6434BA2AQ33904455-367118A7-F3C4-4CBC-A586-A70BAFEB2263Q37316157-4AD74B29-FAB6-4121-881F-571CDED8A4D2Q37466779-06206BA6-5B6F-4BBF-9A5D-5DB63BD13048Q37703261-71614103-CED4-4DFC-BB9C-F0C37E5D531BQ38843982-B7DD3F37-D0E8-4361-9535-CCA131560D84Q38921695-DC290C50-11F1-4DFA-93C3-9250623AEED8Q39458225-3BEE3DC2-808C-447E-8D92-2403FAE36B35Q41874906-CBE25B9D-DA59-46C2-AE02-8480BD0A70F3Q47353483-0C92B07F-4B28-44A9-BF85-066CA8CBAD2FQ49228787-3F7A6754-6C44-4EA8-BB7E-26C5C0782DFFQ50860311-06175923-1FBE-4EC9-AFA3-3151A701A8EDQ55332462-7BE692E5-69F3-4944-B5CC-2F3E3F2810EEQ58493343-BF5E5666-711F-47D2-9864-C5282A311830
P2860
Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9).
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Molecular and cellular functio ...... btilisin/kexin type 9 (PCSK9).
@ast
Molecular and cellular functio ...... btilisin/kexin type 9 (PCSK9).
@en
Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9
@nl
type
label
Molecular and cellular functio ...... btilisin/kexin type 9 (PCSK9).
@ast
Molecular and cellular functio ...... btilisin/kexin type 9 (PCSK9).
@en
Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9
@nl
prefLabel
Molecular and cellular functio ...... btilisin/kexin type 9 (PCSK9).
@ast
Molecular and cellular functio ...... btilisin/kexin type 9 (PCSK9).
@en
Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9
@nl
P2860
P1476
Molecular and cellular functio ...... ubtilisin/kexin type 9 (PCSK9)
@en
P2093
Klaus-Dieter Schlüter
Ulrich Laufs
P2860
P2888
P356
10.1007/S00395-015-0463-Z
P577
2015-01-20T00:00:00Z
P5875
P6179
1005835264